Document is current

Article History

Received: 13 August 2025

Accepted: 5 December 2025

First Online: 8 January 2026

Declarations

:

: Not applicable.

: JMMDLC has received financial grants from Santen, Ivantis, AbbVie, Viatris, Glaukos, and Thea. Additionally, JMMDLC has served as a consultant for AbbVie, Santen, Alcon, Viatris, Novartis, Thea, Bausch & Lomb, Glaukos, AJL, Visufarma, and Angellini. JMMDLC has been a speaker for AbbVie, Santen, Alcon, Viatris, Novartis, Thea, Bausch & Lomb, Glaukos, iCare, and Angellini. PCFV has received financial grants from Pharmacia, Pfizer, Bausch-Lomb, Alcon, Santen, Novartis, and Thea. Additionally, PCFV has served as a consultant for Pharmacia, Pfizer, Bausch-Lomb, Alcon, Allergan, Santen, Novartis, and Thea. PCFV has been a speaker for Pharmacia, Pfizer, Bausch-Lomb, Alcon, Allergan, Santen, Novartis, and Thea. AG has received financial grants from Alcon, Bausch & Lomb, Zeiss, Teleon, CooperVision, Hoya, Essilor, Santen, Viatris, Polpharma, Thea, and Johnson & Johnson. Additionally, AG has served as a consultant for Thea, Santen, Polpharma, Viatris, Eyerising, Essilor, and Alcon. AG has been a speaker for Thea, Santen, Polpharma, Viatris, Eyerising, Essilor, and Alcon. AT has served as a consultant for AbbVie, Viatris, Alcon, Sight Sciences, and Thea. Additionally, AT has received financial grants from AbbVie, Nova Eye Medical, and iStar Medical. AT has been a speaker for Alcon, Viatris, Sight Sciences, Thea, and Nova Eye Medical. SOV is an employee at Viatris and has no other conflicts of interest. TH is an employee and holds shares of Viatris.